日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mastering Organoid Growth: A Complete Guide to Overcoming Methodological Challenges

掌握类器官培养:克服方法学挑战的完整指南

Jiao, Chunbao; Karakaya, Omer Faruk; Dadgar, Neda; Wehrle, Chase J; Massoud, Zahra; Hong, Hanna; Fairchild, Robert L; Leipzig, Nic; Aucejo, Federico; Ma, Wen Wee; Melenhorst, Jan Joseph; Gonzales, Sofia Ferreira; Schlegel, Andrea

Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer

一项针对晚期胰腺癌或结直肠癌患者的BMS-813160(一种CCR2/5双重拮抗剂)联合化疗或纳武利尤单抗的1b/2期研究

Le, Dung T; Folprecht, Gunnar; Varghese, Anna M; Gutierrez, Martin; Noel, Marcus; Trikalinos, Nikolaos A; Chen, Eric; Dayyani, Farshid; Davis, S Lindsey; Ma, Wen Wee; BasuMallick, Atrayee; Garrido-Laguna, Ignacio; Osawa, Mayu; O'Brien, Shaun; Novosiadly, Ruslan D; Xu, Ke; Greenawalt, Danielle M; Dutta, Santanu; Twyman Saint Victor, Christina; Lenz, Heinz-Josef

Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness

成纤维细胞生长因子受体1抑制剂可抑制胰腺癌的化疗耐药性和化疗驱动的侵袭性

Lin, Qingxiang; Serratore, Andrea; Niu, Jin; Shen, Shichen; Roy Chaudhuri, Tista; Ma, Wen Wee; Qu, Jun; Kandel, Eugene S; Straubinger, Robert M

Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

针对胰腺癌患者来源异种移植肿瘤的双重打击治疗策略

Roy Chaudhuri, Tista; Lin, Qingxiang; Stachowiak, Ewa K; Rosario, Spencer R; Spernyak, Joseph A; Ma, Wen Wee; Stachowiak, Michal K; Greene, Michelle K; Quinn, Gerard P; McDade, Simon S; Clynes, Martin; Scott, Christopher J; Straubinger, Robert M

Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancer.

成纤维细胞生长因子受体 1 的表达与单药成纤维细胞生长因子受体特异性抑制剂在胰腺癌中的疗效呈负相关

Lin Qingxiang, Serratore Andrea, Perri Jonathan, Roy Chaudhuri Tista, Qu Jun, Ma Wen Wee, Kandel Eugene S, Straubinger Robert M

Tumor organoids for primary liver cancers: A systematic review of current applications in diagnostics, disease modeling, and drug screening

原发性肝癌的肿瘤类器官:诊断、疾病建模和药物筛选中当前应用的系统性综述

Qureshi, Ayesha A; Wehrle, Chase J; Ferreira-Gonzalez, Sofia; Jiao, Chunbao; Hong, Hanna; Dadgar, Neda; Arpi-Palacios, Jorge; Phong, Yee Phoon; Kim, Jaekeun; Sun, Keyue; Hashimoto, Koji; Kwon, David Ch; Miller, Charles; Leipzig, Nic; Ma, Wen Wee; Melenhorst, Jos; Aucejo, Federico; Schlegel, Andrea

Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy

源自胰腺癌活检的微流控类器官培养物可用于化疗和免疫治疗的个性化测试

Daheui Choi, Alan M Gonzalez-Suarez, Mihai G Dumbrava, Michael Medlyn, Jose M de Hoyos-Vega, Frank Cichocki, Jeffrey S Miller, Li Ding, Mojun Zhu, Gulnaz Stybayeva, Alexandre Gaspar-Maia, Daniel D Billadeau, Wen Wee Ma, Alexander Revzin

Understanding Suboptimal Response to Immune Checkpoint Inhibitors

了解对免疫检查点抑制剂的次优反应

Mojun Zhu, Henan Zhang, Katrina S Pedersen, Nathan R Foster, Brandy L Jaszewski, Xin Liu, Jacob B Hirdler, Zesheng An, Tanios S Bekaii-Saab, Thorvardur R Halfdanarson, Patrick M Boland, Yiyi Yan, Joleen H Hubbard, Wen Wee Ma, Harry H Yoon, Alexander Revzin, Martin E Fernandez-Zapico, Michael J Overm

Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

帕博利珠单抗联合新辅助放化疗治疗可切除的胃食管交界处腺癌患者

Zhu, Mojun; Chen, Chunhua; Foster, Nathan R; Hartley, Christopher; Mounajjed, Taofic; Salomao, Marcela A; Fruth, Briant F; Beamer, Staci E; Kim, Yohan; Harrington, Susan M; Pitot, Henry C; Sanhueza, Cristobal T; Feng, Yening; Herrmann, Joerg; McWilliams, Robert R; Lucien, Fabrice; Huang, Bing Q; Ma, Wen Wee; Bekaii-Saab, Tanios S; Dong, Haidong; Wigle, Dennis; Ahn, Daniel H; Hallemeier, Chris L; Blackmon, Shanda; Yoon, Harry H

Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant Colorectal Cancer

开发基于 SOS1 抑制剂的降解剂以靶向 KRAS 突变型结直肠癌

Yujia Bian, Diego Alem, Francisca Beato, Tara L Hogenson, Xinrui Yang, Kun Jiang, Jianfeng Cai, Wen Wee Ma, Martin Fernandez-Zapico, Aik Choon Tan, Nicholas J Lawrence, Jason B Fleming, Yu Yuan, Hao Xie